chronic insomnia
Conditions
Interventions
Experimental Group:(1)1mg of dzopicone orally once daily
(2)shallow needles therapy once daily and five times a week.
Control Group:1mg of dzopicone orally once daily.
Sponsors
The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) patients who met the diagnostic criteria; (2) insomnia patients aged 18 to 65 years; (3) Pittsburgh Sleep Quality Index (PSQI) score:7~15; (4) the duration of the disease = 3 months (5) no communication and cognitive impairment; (6) voluntary enrollment and signed informed consent.
Exclusion criteria
Exclusion criteria: (1) secondary insomnia; (2) those who do not wish to undergo shallow needles therapy; (3) pregnant or lactating women or those who intend to become pregnant; (4) combined with heart liver kidney lung brain and other serious organic diseases; (5) participants in other studies that influenced the results of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pittsburgh sleep quality index; | — |
Secondary
| Measure | Time frame |
|---|---|
| Magnetic resonance spectroscopy of the thalamus;Sleep structure;Insomnia severity index;Hamilton anxiety scale;To determine the serum levels of melatonin dopamine norepinephrine; | — |
Countries
China
Contacts
Public ContactWanqing Lin
The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine
Outcome results
None listed